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Abstract 
Rheumatic heart disease (RHD) is the commonest acquired heart disease and a major cause of morbidity and 
mortality among children in developing countries. This study sought to determine the clinical profile of 
paediatric patients with RHD at Moi Teaching and Referral Hospital (MTRH), Eldoret, Kenya. It employed a 
cross sectional study in the general peadiatric wards, paediatric outpatient clinic and cardiology clinic at the 
MTRH. The study subjects were children with RHD aged 3 to 15 year. In total, eighty four children (28 boys and 
56 girls) with RHD were enrolled. Data was collected in a structured questionnaire and analyzed using Genstat 
discovery. The study found that the commonest symptoms among new patients were dyspnea, easy fatigability, 
palpitation, cough and orthopnea while the commonest signs were a systolic murmur, a thrill and tachycardia. 
Most new patients presented in NYHA class 3 and 4. Mitral regurgitation alone was the commonest lesion, 
followed by mitral regurgitation + aortic regurgitation. New patients had clinical evidence of severe valvular 
disease and complication implying late presentation. It is thus recommended that emphasis should be put on 
early detection and primary prevention as most new patients have severe disease. 
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1. Introduction 
Rheumatic heart disease (RHD) is the commonest acquired cardiovascular disease in children and young adults. 
It accounts for 12–65% of hospital admissions related to cardiovascular disease, and for 2.0–9.9% of all hospital 
discharges (WHO 1992; 2001). It is a major cause of morbidity, disability and mortality in developing countries. 
An estimated 60 000 children and young adults die annually from rheumatic heart disease. The mortality rate per 
100 000 population varied from 1.8 in the WHO Region of the Americas, to 7.6 in WHO South-East Asia 
Region. A case fatality rate of, 9.7% has been reported in Fiji. The annual mortality is 1.5% per year which is a 
conservative estimate. The most devastating effects are on children and young adults in their most productive 
years (WHO, 2001; Nkomo, 2007; Steer et al., 1999). 
 
Rheumatic heart disease is the most serious complication of rheumatic fever (RF), the disease which “licks the 
joints, but bites the heart” … to put it lightly.  Rheumatic fever develops in children and adolescents following 
pharyngitis infection with group A beta-hemolytic Streptococcus (i.e. Streptococcus pyogenes). The organisms 
attach to the epithelial cells of the upper respiratory tract and produce a battery of enzymes allowing them to 
damage and invade human tissues. After an incubation period of 2-4 days, the invading organisms elicit an acute 
inflammatory response with 3-5 days of sore throat, fever, malaise, headache, and an elevated leukocyte count 
(WHO, 2001). After a latent period of 1-3 weeks, antibody induced immunological damage occur to heart valves, 
joints, subcutaneous tissue and basal ganglia of brain. The processes leading to acute rheumatic fever are still 
poorly understood. New data suggest that a unique surface marker on non-T lymphocytes in patients with 
rheumatic fever and rheumatic heart disease may prove helpful in defining which individuals are susceptible to 
developing rheumatic fever after a streptococcal infection because of abnormal immune responses (Steer et al., 
2009). Rheumatic carditis is present in 40 - 60% of patients with acute rheumatic fever; it ranges from mild to 
severe carditis.
 
Cardiac involvement almost always occurs in recurrent episode. About 90% of children who have 
carditis during rheumatic fever episodes will develop chronic and progressive RHD from inflammation and 
scarring of the heart valves, which may result in haemodynamically significant valvular regurgitation and /or 
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stenosis, heart failure, and death (WHO, 2001). 
 
In addition to the human suffering involved, this vicious disease can also contribute to the crippling of a 
country’s economy. This is not only because of the medical and surgical costs of treatment, but also because it is 
a disease that primarily attacks children, adolescents and young adults (the most economically active group of 
any country) (Cilliers, 2006). 
 
The Key to accurately understanding and diagnosing rheumatic heart disease is to get Clinical profile and real 
time imaging which gives more insight into the nature of the disease and which valves are affected. Currently 
Clinical profiles of rheumatic heart disease in children at the Moi Teaching and Referral Hospital have not been 
documented. 
 
2. Materials and Methods 
The study was conducted at MTRH paediatric wards, outpatient clinic and paediatric and adult cardiac/ 
echocardiography clinic of the Moi Teaching and Referral Hospital (MTRH) using a cross-sectional study design. 
Paediatric patients with rheumatic heart disease aged 3-15 years between October 2009 and October 2010 were 
the target population. Children aged 3-15 years were chosen because the incidence of pharyngeal infections, 
rheumatic fever and RHD is highest in this age group. RHD is uncommon before 3 years of age. 
 
All children who met the clinical diagnosis and American heart association diagnostic criteria of RHD during the 
study period were included. A diagnosis of RHD was based on a combination of history, clinical examination, 
and WHO diagnostic criteria of RHD defined by an expert panel convened under the auspices of the WHO and 
the National Institutes of Health in September 2005.  Children seen in the clinics and wards with a suspected or 
known diagnosis of RHD were re-evaluated by the principal investigator and those with symptoms and signs 
suggestive of rheumatic heart disease were selected for investigation for possible inclusion into the study.  A 
Doppler echocardiography was performed to confirm the diagnosis using the American heart association 
combined criteria for diagnosis of RHD. 
 
The author sensitized the pediatric wards, pediatric outpatient, echocardiographic laboratory and cardiology 
clinic staff on the study. When children with rheumatic heart disease were admitted or seen in the clinic the 
principal investigator was alerted and she evaluated them for possible inclusion in the study. The author then 
evaluated all children with a diagnosis of RHD for the following symptoms and signs; cough, haemoptysis, 
dyspnea, paroxysmal nocturnal dyspnea, orthopnea, chest pain, palpitation, syncope, body swelling, easy 
fatigability, abdominal distention, oedema, murmurs, wasting, tachypnea, cyanosis, tender hepatomegally, thrill 
basal crepitations, and the heart rate and rhythm. New York Heart Association Classification was used in this 
study to estimate the functional capacity of a patient's heart. (NYHA developed as functional classification for 
patients with heart disease) (The Criteria Committee of the New York Heart Association, 1994). 
 
3. Results 
3.1 Demographic characteristics 
The demographic characteristics of the patients who were included in the study are presented in Table 1. A total 
of eighty four children with rheumatic heart disease were enrolled in the study (46 new patients and 38 on 
follow-up treatments). 
Table 1: the demographic characteristics of patients with rheumatic heart disease 
 Patient type  
 No. of  patients with an initial 
diagnosis of RHD 
No. of  patients on follow up Total 
Female 32(38.10%) 24(28.57%) 56(67%) 
Males 14(16.67%) 14(16.67%) 28(33%) 
Total 46(54.76%) 38(45.23%) 84 
 
Overall, there were more female patients 56(67%) than males 28 (33%), with a male to female ratio of 1:2.The 
median age was 11 yrs. (3.5, 15)  
 
There were more new patients than those already on treatment and who were being followed up. 
 
There were no significant differences in nutritional status by gender, with 50 %( 14) and 52 %( 29) of males and 
females respectively having normal weight for age. Forty three percent of both male and female were 
underweight while only 5% of the females and 7% of the male had marasmus. 
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The distribution of patients by age group and nutritional status is presented in Figure 1.  
 
 
Figure 1: Percentage of patients with Rheumatic heart disease (y-axis) having different nutritional status 
within each age group of the population studied 
 
There were 49(58.33%) children aged >10yrs, 31(36.90%) between 6-10yrs and four (4.76%) aged less than 5 
years. 
 
From the population studied, half of the patients (51.19%) had a normal weight for age, 42.68% were under 
weight and 5.95% were marasmus.   
 
The symptoms and signs exhibited by patients with RHD for the population studied are presented in Tables 2 
and 3 respectively. 
 
Table 2: Percentage of patients with RHD exhibiting different symptoms 
Symptoms New patients Patients on follow up P value 
Dyspnea 39(84.78%) 24(63.16%) 0.265
1
 
Easy fatigability 38 (82.61%) 24(63.16%) 0.147
1 
Palpitation 34(73.91%) 18(47.37%) 0.089
1 
Cough 32(69.57% 14(36.84%) 0.416
1 
Orthopnea 29(63.04%) 13(34.21%) 0.660
1
 
Paroxysmal nocturnal dyspnea  29(63.04%) 8(21.05%) <0.001
1
 
Body swelling 24(52.17%) 8(21.05%) 0.003
1
 
Chest pain 19(41.30%) 11(28.95%) 0.175
1 
Abdominal distension 18(39.13%) 4(10.53%) 0.353
1
 
Asymptomatic 6(13.04%) 8(21.05%) 0.992
1
 
Syncope 6(13.04%) 0 0.014
2
 
Haemoptysis 1(2.17%) 0 0.556
2
 
1
chi square test,
2
 fishers exact test 
 
The most common symptoms presented by the new patients were dyspnea, easy fatigability, palpitations, cough 
and orthopnea. Six (13.04%) of the new patients were asymptomatic at presentation; these patients were referrals 
where they were discovered to have had a murmur after presenting for other non-cardiac diseases. 
 
Paroxysmal nocturnal dyspnea and body swelling was significantly more common among the new patients. 
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Table 3: Percentage of patients with RHD exhibiting different signs 
Signs  New patients Patients on follow up P value 
Systolic murmur 41(86.96%) 30(78.95%) 0.458
1
 
Tachycardia  35(76.09%) 20(52.6%) 0.025
1
 
Loud P2 29(63.04%) 16(42.11%) 0.413
1
 
Edema 24(52.17%) 7(18.42%) 0.050
1
 
Wasting  23(50.00%) 12(23.68%) 0.480
1
 
Diastolic murmur 22(47.83%) 13(34.21%) 0.861
1 
Tender hepatomegaly 21(45.65%) 8(21.05%) 0.615
1 
Pallor 18(34.78%) 11(28.05%) 0.079
1
 
Tachypnea  18(39.13%) 6(15.79%) 0.111
1
 
Collapsing pulse 16(34.78%) 7(18.42%) 0.595
1
 
Fever 16(34.78%) 6(15.79%) 0.913
1 
Basal crepitation 15(32.61%) 5(13.16%) 0.721
1 
Increased jugular venous pressure 12(26.09%) 2(5.26%) 0.344
2 
Irregular heart rate 2(4.35%) 0 0.285
2
 
Decreased breath sound 1(2.19%) 1(2.63%) 0.437
2
 
Malar flush 0 0 - 
Cyanosis  0 0 - 
1
chisquare test   ,
 2
 fisher’s exact test 
 
The most common signs exhibited by the new patients were a systolic murmur (89.13%), thrill (78.26%) and 
tachycardia (76.09%) of new the patients. Tachycardia was significantly more common in the newly diagnosed 
patients. 
 
Numbers of patients who were in heart failure and their NYHA class are illustrated in Figure 2 
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Figure 2; NYHA class of patients in heart failure in the different patient cohorts 
 
Eighteen (47.37%) of the patients on follow-up and 36 (78.26%) of the newly diagnosed patients were in heart 
failure. The new patients were mainly in NYHA class 3 and 4. 
 
3.2 New York heart association classification 
A clinical classification of patients was carried out using the New York heart association (NYHA). Comparisons 
of the various patient characteristics within the NYHA classes are presented in Table 4. 
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Table 4: Proportion of patients with various characteristics within each New York heart association 
classification class 
Characteristic NYHA CLASS 
1 2 3 4 Total 
number 
P value 
Gender 
Female 
Male 
 
12(21.43%) 
10(35.71%) 
 
11(19.24%) 
7(25%) 
 
19(33.93%) 
5(17.85%) 
 
14(25%) 
6(21.43%) 
 
56 
28 
 
 
0.126
1
 
 
 
Patient status 
New 
On prophylaxis 
 
7(15.23%) 
15(39.47%) 
 
7(15.23%) 
11(28.95%) 
 
16(34.78%) 
8(21.05%) 
 
16(34.78%) 
4(10.52%) 
 
46 
38 
 
 
<0.001
2
 
 
 
       
Total for each 
class 
22(26%) 18(21%) 24(29%) 20(24%) 84  
1
chisquare test   ,
2
 fishers exact test 
 
Differences in the overall percentage of patients within the four NYHA classes were not large, with 26%, 21%, 
29% and 24% of the patients in classes 1, 2, 3 and 4 respectively.    There were significantly more new patients 
in NYHA classes 3 and 4, than those on secondary prophylaxis who were mainly in NYHA class 1 and 2 ( p 
<0.001). 
 
3.3 Compliance to secondary prophylaxis 
Numbers of patients on prophylaxis and their relative compliance to the secondary prophylaxis are illustrated in 
Figure 3. Generally, most patients were compliant; however, patients who were on secondary prophylaxis for 
less than a year were more likely to be non- compliant. 
 
 
Figure 3: Duration of prophylaxis versus number of compliant and non-compliant patients 
 
Mean duration of follow up was 14.6 month, with a range of 1 month to 6 years. 
 
Twenty nine (76.32%) of the children were compliant while 9(23.68%) were non-compliant. 
 
There were only 9 patients who did not adhere to secondary prophylaxis. Among these patients, the main reasons 
given for non-compliance were lack of finances, long distance to a health facility and lack of understanding on 
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the need for sustained treatment. 
 
3.4 History of rheumatic fever 
Sixty nine (86.96%) patients gave a positive history of rheumatic fever. 
 
3.5 Correlations between main traits present in patients with RHD 
The correlation matrix for the main traits present in patients with RHD is presented in Table 5. 
 
Table 5: Correlation coefficients and probability of significance for main traits present in patients with 
RHD 
Trait Pulmonary 
Hypertension 
Severity of 
Vulvular 
lesions 
Left 
Ventricular 
function 
Number of 
symptoms 
displayed 
Number  
of signs 
displayed 
NYHA 
class 
Pulmonary 
Hypertension 
1 0.618 
(0.0000) * 
0.243 
(0.0261)  
0.648 
(0.0000) * 
0.667 
(0.0000) * 
0.657 
(0.0000) * 
Severity of 
Vulvular lesions 
 1 0.145 
(0.1888) 
0.461 
(0.0000) * 
 
0.558 
(0.0000) * 
0.453 
(0.0000) * 
Left Ventricular 
function 
  1 0.344 
(0.0013) * 
0.352 
(0.0010) * 
0.307 
(0.0052) 
Number of 
symptoms 
displayed 
   1 0.828 
(0.0000) * 
0.802 
(0.0000) * 
Number of signs     1 0.728 
(0.0000) * 
 NYHA class      1 
In brackets are P values, * significant values 
 
All correlations between the traits studied were positive, however, the magnitude of the correlation between the 
traits were different. 
 
The correlation between pulmonary hypertension and the number of symptoms displayed, number of signs 
displayed and NYHA was high (p value, 0.0000), indicating that the greater the number of signs and symptoms 
displayed by patients, the greater the likelihood of the patient having pulmonary hypertension. However, larger 
studies need to be done to find out if these correlations are significant. 
 
4. Discussions 
4.1 Demographic characteristics of patients with rheumatic heart disease 
Rheumatic heart disease continues to be a major health problem in the developing countries. It accounts for a 
large percentage of cardiovascular disease related paediatrics admissions in Kenya.  The last prevalence study 
that was done in 1992-1994 in Kenya showed a high prevalence (27/1000) of RHD, results which are consistent 
with recent studies in other developing countries (Steer et al., 1999). However; this is in contrast to its virtual 
extinction in the developed world. 
 
Results from this study revealed that there were more females, than male with RHD, with a male to female ratio 
of 1:2. This is similar to Karen Sliwa’s et al,.2010  study in Soweto, South Africa where African females had a 
prevalence of 68%, Essein et al., 2008. in Nigeria and Paar et al., 2010 in Nicaragua. Other recent studies (Halim, 
& Jacques, 1961; Sadiq et al., 2009; Paar et al., 2010; Aly et al., 1997; Danbauchi et al., 2004; Folger et al., 
1992; Sani et al., 2007; Ayub, 2009;  Veasy  et al., 1994; Siddig et al., 1992 and Essien, 2008) have however 
depicted either no difference in the prevalence of RHD amongst males and females, or depicted females as the 
dominant patient population while others depicting males as the most predominant gender. Rheumatic fever and 
RHD are more severe and have a worse prognosis in females than in males. Women produce more vigorous 
immune response and increased antibody production and estrogen significantly increases proinflammatory 
cytokine productions thus the elevated immune response in females may even further amplify the adjuvant effect 
of infection thus putting them more at risk of chronic autoimmune diseases (DeLisaFairweather & Rose, 2004).
 
This may account for the high number of females in this study, because they are more likely to be symptomatic 
and hence brought into hospital for treatment (Chin  et al., 2010). 
 
Children aged less than 5 years were the least prevalent forming 4.8% of those with RHD while those aged 5-
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15yrs had a prevalence of approximately 95%. This is similar to what was found by Yuko- Jowi at Kenyatta 
National Hospital who found that 76.4% of cases were aged between 5 and 15 years, while only 3% were less 
than 5 years old (Yuko-Jowi, 2005).Almost half of children studied had a weight that was less than 80% weight 
for their age (either underweight or marasmic). This could be because of the disease process. Patients with 
rheumatic heart disease, especially mitral valve disease, are most likely to have cardiac cachexia, but nearly all 
patients with cardiac disease demonstrate wasting of body fat and skeletal muscle, with muscular weakness and 
easy fatigability. This is due to disturbances in neuroendocrine, inflammatory, and metabolic systems; anorexia 
from chronic illness, the unpalatability of a low salt diet, and to a great extent to poor cardiac output due to heart 
failure. In this study, evidence for cardiac cachexia may be seen in the fact almost half of the patients had 
advanced tricuspid regurgitation which is one of the major criteria for diagnosis of cardiac cachexia in patients 
with mitral valve diseases. Sadif in Pakistan found a higher prevalence (67%) undernourished children with 
RHD (Sadiq et al., 2009). 
 
4.2 Clinical profile of patients 
The commonest symptoms were dyspnea, palpitation and easy fatigability, while the commonest signs were 
systolic murmur, tachycardia and a thrill. Thirteen percent of the new patients were asymptomatic they came into 
MTRH as referrals where they were discovered to have had a murmur after presenting for other non-cardiac 
diseases/symptoms. 
 
Almost three quarters of the patients were symptomatic. This is contrary to what would be expected in a 
population where the commonest valvular lesion is isolated MR. In most cardiology literature patients with mild 
to moderate MR are usually asymptomatic. The reason for this difference is that most patients in this study had 
severe valvular disease with complications of pulmonary hypertension and also because MTRH being a referral 
hospital receives very sick patients. Daniel Bernstein reported that easy fatigability and dyspnea is present in 
over 70% of the patients, this corroborates with what was found in this study. Fatigability and dyspnea are 
common in patients with severe MR and moderate to severe MS (WHO, 2001). 
 
There was an almost equal distribution of patient in all the NYHA classes when all the patients were analyzed 
together. Almost three quarters of the new patients came in stage 3 and 4. . There was an association between the 
NYHA class and severity of valvular lesion. Only 13% of the new patients were asymptomatic showing that 
most patients seek medical attentions when they are very sick and probably having severe disease. 
 
The mean duration of secondary prophylaxis was 14.6 month and a range of 1 month to 6 yrs. Kimberly-Leaky 
in Brazzaville found compliance of 75% after one month of follow-up and 37.5% after 3 month of follow-up, 
this is contrary to what was found in this study where patients who were on prophylaxis for a longer duration 
were more compliant than patients who were on it for a shorter duration (Kimbally-leaky, 2008).   Almost a 
quarter of the patients on prophylaxis were non-compliant with lack of knowledge, lack of finances and long 
distance to nearest health facility being the main reasons for non-compliance. There were however few non-
compliant patients (9 patients). This study was a cross-sectional study hence could not find out the dropout rates 
from secondary prophylaxis which is an important parameter (Alkhalifa et al., 2008). 
 
4.3 Correlations between main traits present in patients with RHD 
The greater the number of signs and symptoms displayed by patients, the greater the likelihood of the patient 
having pulmonary hypertension. There was also a positive and strong correlation between the New York heart 
association and the severity of pulmonary hypertension. This is consistent with the WHO classification of 
pulmonary hypertension which is a modification of New York heart associations where patients who are more 
symptomatic and have right sided heart failure have a worse WHO pulmonary hypertension classification (WHO, 
1998). 
 
5. Conclusion and Recommendations 
From the study findings, the commonest symptoms of new patients at MTRH were dyspnea, easy fatigability, 
palpitations, cough and orthopnea while the commonest signs were systolic murmur, thrill and tachycardia. A 
significant number of patients were asymptomatic. Patients who were non-compliant to secondary prophylaxis 
were more likely to have severe valvular lesion and pulmonary hypertension. 
 
From the study findings most of the new patients had severe disease at diagnosis; therefore, it is recommended 
that emphasis should be put on early detection and primary prevention. This entails eradication of pharyngeal 
streptococci through appropriate antibiotics therapy and   long-term secondary prophylaxis to guard against 
recurrent pharyngeal streptococcal infection for children with acute rheumatic fever. 
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